Should I Buy HLNE? HLNE 2026 Analysis

Should You Buy Hamilton Lane Inc (HLNE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

142.690

1 Day change

-4.00%

52 Week Range

179.190

Analysis Updated At

2026/01/29

BUY for a beginner long-term investor right now. HLNE shows strong fundamental momentum (2026/Q2 revenue +37% YoY, EPS +23% YoY), improving Wall Street targets, and supportive long-term private-markets demand. Technicals are broadly bullish on moving averages, and options positioning (put-call OI < 1) leans constructive. Even if the stock chops short-term into earnings, the current level around ~$148 is a reasonable long-term entry for an impatient investor who doesn’t want to wait for a perfect pullback.

Technical Analysis

Trend is mildly bullish but with short-term softness. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), suggesting the broader uptrend remains intact. However, MACD histogram is negative and expanding (-0.775), indicating near-term downside/weak momentum. RSI_6 ~49.6 is neutral (no overbought risk, but not a strong momentum breakout either). Price is below the pivot (149.878), so the near-term tone is slightly defensive; key support sits at S1 145.308 (then S2 142.484) and resistance is R1 154.449 (then R2 157.273). Pattern-based projection provided implies a modest next-day dip but a positive 1-month bias (~+5.95%). Intellectia Proprietary Trading Signals: **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): No signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Options sentiment leans bullish based on positioning: open interest put/call ratio at 0.62 (more calls than puts outstanding). Implied volatility (30D) is elevated vs historical (IV ~53.9 vs HV ~34.8), which often reflects event risk (notably the upcoming earnings on 2026-02-03). Option volume is effectively 0 in the provided snapshot, so the signal is more about positioning than active near-term speculation.

Technical Summary

Sell

Buy

Positive Catalysts

1) Strong growth in the latest reported quarter (2026/Q2: revenue +37% YoY, net income +29% YoY, EPS +23% YoY). 2) Analyst price targets have been raised repeatedly, with multiple Buy/Outperform stances (notably Oppenheimer $220). 3) Sector/news tailwind: financial advisors planning to increase engagement with private markets, supportive for alternative managers like Hamilton Lane. 4) Earnings catalyst upcoming (2026-02-03 pre-market) could validate growth narrative if results/guide are strong.

Neutral/Negative Catalysts

1) Short-term momentum is weakening (MACD negative and expanding), increasing the chance of near-term chop/pullback. 2) Elevated implied volatility suggests the market is pricing meaningful earnings-related moves; a miss or cautious outlook could pressure shares. 3) Stock is currently below the pivot level (~149.9), so it may need to reclaim that area to re-accelerate upward.

Financial Performance

Latest quarter provided: 2026/Q2. Revenue increased to $208.8M (+37.07% YoY). Net income rose to $70.9M (+28.93% YoY). EPS increased to $1.69 (+23.36% YoY). Overall, this is a strong growth profile with earnings expanding alongside revenue, consistent with a long-term compounder in private markets/alternatives.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend is clearly improving: multiple firms raised price targets over the past few months. Key updates include: Morgan Stanley raised PT to $159 (Equal Weight), Oppenheimer raised PT to $220 (Outperform), Keefe Bruyette raised PT to $170 (Outperform), UBS initiated Buy with $166, and Goldman upgraded to Buy with $165. Wall Street ‘pros’ view: durable growth exposure to wealth + secondaries, product expansion and structural private-market tailwinds, and room for valuation upside. ‘Cons’ view: some concern about valuation/expectations (implied by Equal Weight at Morgan Stanley) and sensitivity to deal activity/market conditions. Influential/political trading: no congress trading data and no notable politician activity provided; hedge funds/insiders shown as neutral with no significant recent trend.

6 Analyst Rating

Wall Street analysts forecast HLNE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLNE is 166.67 USD with a low forecast of 154 USD and a high forecast of 181 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

2 Hold

0 Sell

Moderate Buy

Current: 148.640

Low

154

Averages

166.67

High

181

Current: 148.640

Low

154

Averages

166.67

High

181

Morgan Stanley

Equal Weight

maintain

$154 -> $159

AI Analysis

2026-01-27

New

Reason

Morgan Stanley

Price Target

$154 -> $159

AI Analysis

2026-01-27

New

maintain

Equal Weight

Reason

Morgan Stanley raised the firm's price target on Hamilton Lane to $159 from $154 and keeps an Equal Weight rating on the shares. Ramping deal activity should be supportive for the alternative asset managers into Q4 and 2026, says the analyst, who raised EPS estimates by 4% and 1% ahead of consensus on average among the group as part of the firm's Q4 earnings preview.

Oppenheimer

Outperform

maintain

$190 -> $220

2026-01-20

Reason

Oppenheimer

Price Target

$190 -> $220

2026-01-20

maintain

Outperform

Reason

Oppenheimer raised the firm's price target on Hamilton Lane to $220 from $190 and keeps an Outperform rating on the shares. The firm adjusted targets in the alternative asset manager group as part of a Q4 preview.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HLNE

Unlock Now

HLNE Should I Buy

HLNE Should I Buy

Should You Buy Hamilton Lane Inc (HLNE) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch